ArticleScientific reports2020

Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.

Vaclav Janovec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.